According to Medpace's latest financial reports the company's current earnings (TTM) are $0.36 B. In 2022 the company made an earning of $0.28 B an increase over its 2021 earnings that were of $0.20 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.33 B | 18.67% |
2022 | $0.28 B | 40.13% |
2021 | $0.20 B | 19.77% |
2020 | $0.16 B | 35.01% |
2019 | $0.12 B | 32.87% |
2018 | $93.95 M | 64.99% |
2017 | $56.94 M | 159.35% |
2016 | $21.95 M | -380.42% |
2015 | -$7.83 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -130.57% | ๐บ๐ธ USA |